David E. Wexler

Gastroenterology

727 Raritan Road
Suite 101
Clark, NJ 7066.

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Effect of hepatic or renal impairment on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor.

Effect of hepatic or renal impairment on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor.

Journal: Clinical therapeutics

Published: September 18, 2014

Showing 1-1 of 1

Last Updated: 09/26/2026